Sustained-release, extended-release, and other time-release formulations in neuropsychiatry

Pills and capsules may release their contents within minutes of ingestion; these are immediate-release formulations. Pills and capsules may also release their contents after a time lag, or a little at a time, or in some other predetermined way; these are time-release formulations. Many drugs in psychiatry have been time-release formulated to reduce their local adverse effects in the gastrointestinal tract, to reduce adverse effects associated with peak blood levels, or to artificially extend their half-life. Time-release formulations are associated with the added advantages of convenience of dosing, improved compliance, and less fluctuation in blood levels across the course of the day. A disadvantage of time-release formulations is that they may be incompletely absorbed; this is a serious issue in patients with acute or chronic intestinal hurry disorders, such as gastroenteritis or irritable bowel syndrome. Time-release formulations may also be more expensive than immediate-release formulations.

© Copyright 2015 Physicians Postgraduate Press, Inc.

Similar articles

Keith S. Keith S. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):996-1008. doi: 10.1016/j.pnpbp.2006.03.031. Epub 2006 May 6. Prog Neuropsychopharmacol Biol Psychiatry. 2006. PMID: 16678954 Review.

Gudin JA. Gudin JA. J Pain Palliat Care Pharmacother. 2013 Mar;27(1):49-61. doi: 10.3109/15360288.2012.757575. J Pain Palliat Care Pharmacother. 2013. PMID: 23527669 Review.

Leppik IE, Hovinga CA. Leppik IE, et al. Epilepsia. 2013 Jan;54(1):28-35. doi: 10.1111/epi.12043. Epub 2012 Nov 28. Epilepsia. 2013. PMID: 23190215 Review.

Bonora Regazzi M, Rondanelli R, Vidale E, Cristiani D. Bonora Regazzi M, et al. Int J Clin Pharmacol Ther Toxicol. 1983 May;21(5):245-51. Int J Clin Pharmacol Ther Toxicol. 1983. PMID: 6862729

Dulac O, Alvarez JC. Dulac O, et al. Pharmacotherapy. 2005 Jan;25(1):35-41. doi: 10.1592/phco.25.1.35.55626. Pharmacotherapy. 2005. PMID: 15767218 Clinical Trial.

Cited by

Hedin KA, Zhang H, Kruse V, Rees VE, Bäckhed F, Greiner TU, Vazquez-Uribe R, Sommer MOA. Hedin KA, et al. ACS Synth Biol. 2023 Nov 17;12(11):3433-3442. doi: 10.1021/acssynbio.3c00455. Epub 2023 Oct 12. ACS Synth Biol. 2023. PMID: 37827516 Free PMC article.

Abdallah MH, Abdelnabi DM, Elghamry HA. Abdallah MH, et al. Gels. 2022 Jun 22;8(7):395. doi: 10.3390/gels8070395. Gels. 2022. PMID: 35877480 Free PMC article.

Senthilvel CK, Karuppaiyan K, Pothumani A, Vedharethinam A, Jose AW, Muthu Mohamed JM, Sherbiny ME, Ebrahim HA, Shafey ME, Dejene M. Senthilvel CK, et al. Evid Based Complement Alternat Med. 2022 May 16;2022:4995508. doi: 10.1155/2022/4995508. eCollection 2022. Evid Based Complement Alternat Med. 2022. Retraction in: Evid Based Complement Alternat Med. 2023 Aug 9;2023:9780462. doi: 10.1155/2023/9780462. PMID: 35615690 Free PMC article. Retracted.

Sundar V, Ramasamy T, Doke M, Samikkannu T. Sundar V, et al. Redox Rep. 2022 Dec;27(1):53-59. doi: 10.1080/13510002.2022.2043224. Redox Rep. 2022. PMID: 35227168 Free PMC article. Review.

Ramos TI, Villacis-Aguirre CA, Santiago Vispo N, Santiago Padilla L, Pedroso Santana S, Parra NC, Alonso JRT. Ramos TI, et al. Pharmaceutics. 2021 Sep 22;13(10):1533. doi: 10.3390/pharmaceutics13101533. Pharmaceutics. 2021. PMID: 34683824 Free PMC article. Review.